|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Efficacy and Safety of Ivermectin Versus Albendazole for Chronic Strongyloidiasis
A prospective controlled trial to compare the efficacy and safety of 7-day albendazole, single dose ivermectin, and 2-single dose ivermectin in 72 patients with chronic strongyloidiasis will be conducted at Siriraj Hospital, Bangkok, Thailand.
100 Clinical Results associated with Atlantic Laboratories Corp. Ltd.
0 Patents (Medical) associated with Atlantic Laboratories Corp. Ltd.
100 Deals associated with Atlantic Laboratories Corp. Ltd.
100 Translational Medicine associated with Atlantic Laboratories Corp. Ltd.